HOME
HIV-HCV Coinfection
Hepatitis C
HIV and AIDS
Hepatitis B
HIV-HBV Coinfection
HIV-HCV Coinfection
Main Section
 Google Custom Search
HIV-HCV Coinfection Top News Articles
Treatment of Patients with HIV-HCV Coinfection: An Overview

Guidelines for Management of HIV-HCV Coinfection
Advanced Liver Disease in People with HIV - 12/10/08
Blood Lipid Levels and Insulin Resistance Predict Response to Interferon-based Therapy in HIV-HCV Coinfected Patients - 12/05/08
Ritonavir (Norvir), but Not Abacavir (Ziagen), Adversely Influences Hepatitis C Treatment in HIV-HCV Coinfected Patients - 11/25/08
Does Antiretroviral Therapy Reduce Ribavirin Levels in HIV-HCV Coinfected Individuals? - 11/25/08
Partial Rapid Virological Response Predicts Sustained Response in HCV-HIV Coinfected Patients, APRICOT Analysis Shows - 11/21/08
Outcomes of Acute Hepatitis C Virus Infection in People with HIV - 11/21/08
Liver Fibrosis Progression in HIV-HCV Coinfected Individuals - 11/11/08
Liver Fibrosis Progression in HIV-HCV Coinfected Individuals - 11/07/08
Comparison of Non-invasive Biomarkers for Predicting Liver Fibrosis in HIV-HCV Coinfected Individuals - 10/24/08
Response to Pegylated Interferon plus Ribavirin in HIV-HCV Coinfected Patients with HCV Genotype 4 - 10/21/08
Lower CD4 Count Linked to Increased Risk of Liver Cancer in HIV Positive People, Especially Those with Hepatitis B Coinfection - 10/10/08
Detectable HCV in Peripheral Blood Cells after Interferon-based Therapy Predicts Relapse in HIV-HCV Coinfected Patients - 10/07/08
Hepatitis C Virus Spontaneous Clearance, Viral Load, and Genotype Distribution in HIV-HCV Coinfected Patients in Europe - 10/03/08
Use of HIV Protease Inhibitors Does Not Promote Hepatitis C Virus Protease Mutations in HIV-HCV Coinfected Individuals - 9/26/08
HIV-related Immune Suppression Does Not Promote Genetic Divergence of Hepatitis C Virus in HIV-HCV Coinfected Individuals - 9/23/08
The Impact of Hepatitis C Virus Coinfection on HIV-related Kidney Disease - 9/23/08
Liver Fibrosis Progression Rates in HCV Monoinfected and HIV-HCV Coinfected Individuals - 9/16/08
Higher Ribavirin Concentration is Associated with Improved Treatment Response in HIV-HCV Coinfected Individuals - 9/12/2008
HIV-HCV Coinfected Pregnant Women More Likely to Have Detectable HIV despite HAART, Raising Risk of Mother-to-child HIV Transmission - 9/5/08
Milk Thistle Compound Silymarin Safe and Potentially Effective for HIV-HCV Coinfected Patients on HAART - 8/31/2008
HIV-HCV Coinfected Patients May Have Fewer Psychiatric Comorbidities than People with HCV Alone - 8/26/2008
HIV Positive Individuals Are at Higher Risk of Occult Hepatitis B Virus Infection, but Occult Hepatitis C Virus Is Rare - 8/26/2008
Risk of Mother-to-Child HIV and HCV Transmission from Coinfected Pregnant Women - 8/22/2008
Are HIV Positive People More Likely to Relapse after Completion of Hepatitis C Treatment with Pegylated Interferon plus Ribavirin - 8/22/2008
Further Evidence of Sexual Transmission of Hepatitis C Virus among HIV Positive Men Who Have Sex with Men - 8/19/2008
Do HIV-HCV Coinfected Patients Respond Better to Pegasys or PegIntron as Part of Combination Therapy for Chronic Hepatitis C? - 8/19/2008
HIV-HCV Coinfected Individuals May Have a Higher Risk of Cardiovascular Disease than HIV Positive People without Hepatitis C - 8/15/2008
Body Weight Affects Relapse Rates in Latinos with Genotype 2/3 Hepatitis C Treated with Pegylated Interferon Alfa-2a (Pegasys) plus Ribavirin - 8/15/2008
Hepatitis C Virus Kinetics during the First 24 Hours of Treatment Predicts Rapid and End-of-treatment Response in HIV-HCV Coinfected Patients - 8/08/2008
Severe Liver Fibrosis during Acute HCV Infection in HIV Positive Men Who Have Sex with Men - 8/05/2008
Review Articles Provide Overview of Epidemiology and Management of HIV-HCV Coinfection - 8/01/08
Pharmacokinetics of Lopinavir/ritonavir (Kaletra) in HIV-HCV Coinfected Patients with or without Liver Cirrhosis - 7/29/08
HIV-HCV Coinfected People Taking Modern HAART Regimens Show No Evidence of Liver Mitochondrial Toxicity - 7/29/08
Biomarker Tests Accurately Predict Extent of Liver Fibrosis in HIV-HCV Coinfected Individuals - 7/22/08
Serum Alpha-fetoprotein Level Predicts Sustained Response to Hepatitis C Treatment in HIV Positive Patients - 7/22/08
Can Rapid Virological Response Predict Sustained Response to Pegylated Interferon plus Ribavirin in HIV-HCV Coinfected Patients? - 7/18/08
HIV-HCV Coinfection Does Not Impair CD4 Cell Recovery after Starting Antiretroviral Therapy - 7/11/08
FDA Revises Process for Responding to Drug Approval Applications from Pharmaceutical Companies - 7/11/08
Is Pegylated interferon Monotherapy the Best First-line Treatment for Acute Hepatitis C in HIV Positive Individuals? - 7/08/08
Effect on Hepatitis C Virus Load in HIV-HCV Coinfected Patients Who Start Protease Inhibitor-based HAART - 7/04/04
HCV-Related Liver Fibrosis Is More Severe in HIV Positive Individuals Despite Antiretroviral Therapy - 6/24/08
Abdominal Fat Accumulation, Elevated ALT, and Liver Steatosis in HIV Positive Individuals - 6/20/08
Profile of Patients Triply-infected with HIV, Hepatitis B and Hepatitis C - 6/16/08
Liver Biopsies Reveal No Evidence of Mitochondrial Damage in HIV-HCV Coinfected Individuals on HAART - 6/13/08
Influence of Occult Hepatitis B Virus on Liver Disease Progression and Response to Interferon-based Therapy in HIV-HCV Coinfected Patients - 6/10/08
HIV Coinfection May Interfere with Immune Response to Hepatitis C Virus - 6/06/08
Long-term Alcohol Abuse Is Linked to Worse Liver Fibrosis in HIV Positive Veterans with or without HCV Coinfection - 6/03/08
Sexual Transmission of HCV and Triple Infection with HBV Predict Spontaneous HCV Clearance in HIV-HCV Coinfected Individuals - 5/30/08
Higher LDL Cholesterol Predicts Better Response to Interferon-based Therapy in HIV-HCV Coinfected Patients - 5/23/08
Insulin Resistance Impairs Rapid Virologic Response to Interferon-based Therapy in HIV-HCV Coinfected Patients - 5/13/08
Virological Response Is Similar in HCV Monoinfected and HIV-HCV Coinfected Patients with HCV Genotypes 2 or 3 - 5/13/08
Liver Transplant Outcomes in HIV Positive Patients with Viral Hepatitis - 4/29/08
Altered Cytokine Levels May Explain More Rapid Liver Fibrosis Progression in HIV-HCV Coinfected Individuals  - 4/15/08
Prevalence and Outcomes of Liver Cirrhosis in HIV Positive People  - 4/11/08
Liver Steatosis Is Common in People with HIV-HCV Coinfection and Is Linked to Advanced Fibrosis - 4/01/08
Severe Weight Loss Can Be a Side Effect of Interferon-based Therapy in HIV-HCV Coinfected Patients - 3/28/08
Liver Steatosis and its Effect on Hepatitis C Treatment in HIV-HCV Coinfected Individuals - 3/21/08
Acute HIV-HCV Coinfection Increasingly Common in U.K.; Sexually Transmitted HCV Superinfection Reported in France - 3/18/08
Researchers Uncover Clues to How HIV Promotes Hepatitis C Virus Replication - 3/14/08
Cyclophilin Inhibitor Debio-025 Demonstrates Potent Anti-HCV Activity in HIV-HCV Coinfected Patients - 3/14/08

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reports on Most Recent
HIV- and Hepatitis-related Research Conferences

AASLD 2008 - November 2008 
DDW 2008 - May 2008 
EASL 2008 - April 2008 
CROI 2008 - February 2008 

IAS 2007 - July 2007 


FDA-approved Hepatitis C
Treatments

Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin
-
Treatment Guidelines
-
Experimental Treatments

FDA-approved HIV and
AIDS Treatments

Protease Inhibitors PIs
non Nucleoside Reverse
  
Transcriptase Inhibitors nNRTIs
Nucleoside / Nucleotide Reverse
  
Transcriptase Inhibitors NRTIs

Fixed-dose Combinations

Entry / Fusion Inhibitors EIs
Integrase Inhibitors
-
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
-Guidelines for Treatment of HIV-related OIs
-
Experimental Treatments


Website Sponsors